Saturday March 20 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z
Shigellosis Shigella News and Headlines
Shigellosis Shigella news updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's Shigellosis Shigella news alerts.
Site Map > Biotechnology News > Health News > Shigellosis Shigella.

 

Identification and characterization of CTX-M-producing Shigella isolates in the United States [Article]
AAC:  similar ...
What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
PR inside:  similar ...
CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram
DiagnosticMicrobiology and Infectious Disease:  similar ...
Targeted antibiotics tackle bacterial resistance
Australian Life Scientist:  similar ...
GlycoVaxyn AG - Pharmaceuticals & Healthcare - Deals And Alliances Profile - New Report Published
OfficialSpin:  similar ...
Identification and characterization of CTX-M-producing Shigella isolates in the United States
AAC:  similar ...
GlycoVaxyn AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report released
PR inside:  similar ...
Prevalence of plasmid-mediated quinolone-resistance determinants in Shigella flexneri isolates from Anhui Province, China
Journal of Antibiotics:  similar ...
GlycoVaxyns First Clinical Study with Bioconjugate Vaccine Initiated
Bionity.com:  similar ...
GlycoVaxyn's First Clinical Study With Bioconjugate Vaccine Initiated
Medical News Today:  similar ...
GlycoVaxynEURs First Clinical Study with Bioconjugate Vaccine Initiated
PharmiWeb:  similar ...
Medical News: GlycoVaxyn's First Clinical Study With Bioconjugate Vaccine Initiated
BioFind:  similar ...
Anti-diarrheal drugs may not be right for all cases
SmartBrief:  similar ...
GlycoVaxyn's First Clinical Study with Bioconjugate Vaccine Initiated
Therapeutics Daily:  similar ...
GlycoVaxyn's First Clinical Study with Bioconjugate Vaccine Initiated
Pharma Live:  similar ...
GlycoVaxyn initiates Phase I clinical study of GVXN SD133 vaccine candidate against Shigella dysenteriae
News-Medical.Net:  similar ...
GlycoVaxyns First Clinical Study with Bioconjugate Vaccine Initiated
Genetic Engineering News:  similar ...
GlycoVaxyns First Clinical Study with Bioconjugate Vaccine Initiated
Yahoo! Canada:  similar ...
GlycoVaxyn Initiates First Clinical Study With Shigella Vaccine
Pharmaceutical Business Review:  similar ...
Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei
MDLinx:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 
BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.